LSP Life Sciences Fund Monthly Report August 2013 € NAV per Share

Source URL: www.lspvc.com

• Investment
• Financial services
• Funds
• Collective investment schemes
• Financial economics
• MorphoSys
• Genmab

Media Release Martinsried/Munich, Germany, and Groningen, The Netherlands, May 7, 2015 MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma Acquisition Adds Novel Candidates Including Pre-IND Candidate for Fibro

Source URL: www.biogenerationventures.com

Media Release Martinsried/Munich and Darmstadt, Germany, 12 June 2014 MorphoSys and Merck Serono Enter Strategic Immuno-Oncology Collaboration 

Source URL: hugin.info

Medienmitteilung Martinsried/München, 21. Mai 2015 MorphoSys präsentiert Daten zu firmeneigenen Programmen auf dem 20ten Kongress der European Hematology Association Aussagekräftige Datenpakete zu den am weitesten for

Source URL: hugin.info

Media Release Martinsried/Munich, Germany, January 10, 2013 MorphoSys Completes Sale of AbD Serotec to Bio-Rad MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that the sale of its research and dia

Source URL: hugin.info

• MorphoSys
• TecDAX
• Bio-Rad Laboratories

Media Release Martinsried/Munich, Germany, and Groningen, The Netherlands, November 27, 2012 MorphoSys and Lanthio Pharma Sign Technology Alliance on New Class of Therapeutic Peptides MorphoSys to Participate in Lanthio

Source URL: hugin.info

• MorphoSys
• TecDAX
• Peptide
• G protein-coupled receptor
• Drug discovery
• Pharmaceutical sciences
• Pharmacology
• Biology

Media Release Martinsried/Munich, Germany, 10 May 2013 MorphoSys Announces First Scientific Publication on Novel Antibody Platform Ylanthia MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX) announced today that a

Source URL: hugin.info

• Immunology
• Glycoproteins
• Biotechnology
• Monoclonal antibodies
• Antibody
• MAbs
• TecDAX
• Immune system
• Biology
• MorphoSys

Media Release Martinsried/Munich, Germany, July 5, 2012 MorphoSys Partner OncoMed Publishes Data on HuCAL Antibody OMP-18R5 Preclinical Data Published in PNAS Demonstrates Potent Anti-Cancer Activity of

Source URL: hugin.info

• Signal transduction
• Wnt signaling pathway
• Immunology
• Monoclonal antibodies
• Antibody
• Biology
• Immune system
• MorphoSys

Ad hoc Mitteilung gemäß § 15 AktG Martinsried/München, 22. Oktober 2014 MorphoSys aktualisiert Finanzprognose 2014 Die MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) hat heute die Aktualisi

Source URL: hugin.info

Medienmitteilung Martinsried/München, 22. Oktober 2014 MorphoSys erhält klinische Meilensteinzahlung für Phase 3-Start mit dem Antikörper Guselkumab Die MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX, O

Source URL: hugin.info